Dyslipidaemia

 

Diabetic patients are at increased risk of developing dyslipidaemia. One mechanism underlying this connection is increased free fatty-acid release present in insulin-resistant fat cells. High levels of free fatty acids promote triglyceride production, which in turn stimulates the secretion of Apo lipoprotein B (ApoB) and very LDL (VLDL) cholesterol. High levels of ApoB and VLDL have both been tied to increased risk of CVD. In addition to high ApoB and VLDL, hyperinsulinemia is associated with low high-density lipoprotein (HDL) cholesterol levels. Hyperglycaemia may also negatively impact lipoproteins (particularly LDL and VLDL) through increased glycosylation and oxidation, decreasing vascular compliance and facilitating the development of aggressive atherosclerosis. High circulating FFA’s and triglycerides, increased stimulation of ApoB and VLDL cholesterol, decreased HDL levels and lipoprotein modification have all been appreciated in patients with DM and likely contributes to the high prevalence of CVD in diabetic patients.

    Related Conference of Dyslipidaemia

    May 30-31, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Istanbul, Turkey
    July 29-30, 2019

    21st Asia Pacific Diabetes Conference

    Sydney, Australia
    June 27-28, 2019

    18th Global Conference on Diabetes & Nursing Care

    Amsterdam, Netherlands
    July 17-18, 2019

    28th European Diabetes Congress

    | Edinburgh, Scotland
    September 16-17, 2019

    International Conference on Diabetes and Heart diseases

    Athens, Greece
    September 20-21, 2019

    15th World Congress on Endocrinology & Diabetes

    | Prague, Czech Republic
    September 20-21, 2019 |

    Euro Diabetes Congress & Expo

    Prague, Czech Republic
    October 14-15, 2019

    Global congress on Endocrinology and Gynecology

    Sydney, Australia
    October 23-24, 2019

    World conference on Diabetes and Heart Congress

    Valencia,Spain
    October 23-24, 2019

    Annual Summit on Metabolomics

    Amsterdam, Netherlands
    October 25-26, 2019

    29th World Diabetes & Heart Congress

    | Radisson Narita | Tokyo, Japan
    November 25-26, 2019

    Global Summit On Diabetes & Endocrinology

    Yokohama, Japan
    November 29-30, 2019

    World conference on Diabetes and Endocrine Complications

    Barcelona,Spain
    December 02-03, 2019

    14th European Diabetes and Endocrinology Congress

    | Barcelona, Spain
    December 04-05, 2019

    3rd Annual Congress on Diabetes and Its Complications

    Tokyo, Japan
    December 12-13, 2019

    Annual Congress on Diabetes and Endocrinology

    | Dubai, UAE

    Dyslipidaemia Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in